Newsroom

LYON, France--(BUSINESS WIRE)--Brenus Pharma a annoncé aujourd’hui des nominations clés au sein de son conseil d’administration. La société accueille Eric DESSERTENNE au poste de président-directeur général et président du conseil d’administration, succédant ainsi au cofondateur Jacques GARDETTE, qui restera membre actif du conseil. Eric apporte une vaste expérience en matière d’innovation dans le domaine de la santé et de création de valeur, ayant notamment dirigé BIOCORP tout au long de son d...

PEMBROKE, Bermuda--(BUSINESS WIRE)--RenaissanceRe Holdings Ltd. (NYSE: RNR) (the “Company” or “RenaissanceRe”) will conduct an investment community conference call on Thursday, July 23, 2026, at 10:00 a.m. ET to discuss its financial results for the second quarter of 2026, as well as the Company’s outlook. RenaissanceRe will release its results following the close of market on Wednesday, July 22, 2026. A live webcast of the conference call will be available through the Investors section of Rena...

ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab today announced the close of its acquisition of CoolIT Systems, a leader in direct liquid cooling for high‑density data centers. The transaction closed earlier than expected, and Ecolab welcomes the world-class CoolIT team to the company. Ecolab acquired CoolIT for approximately $4.75 billion. CoolIT’s year‑to‑date sales have grown more than 100%, driven by accelerating demand for liquid cooling in AI data centers. With CoolIT, Ecolab extends its establi...

CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty”), a leading international specialty insurance firm, today announced it will release its Second Quarter 2026 financial results after the market closes on Thursday, July 30, 2026.Ryan Specialty will hold a conference call to discuss the financial results at 4:45pm Eastern Time on July 30, 2026. Interested parties may access the conference call through the live webcast, which can be registered for via this link o...

ORLANDO, Fla.--(BUSINESS WIRE)--Hilton Grand Vacations Announces Appointment of Christine Duffy to its Board of Directors...

WASHINGTON--(BUSINESS WIRE)--Xylem Inc. (NYSE: XYL), a leading global water solutions company that empowers customers and communities to build a more water-secure world, will release its second quarter 2026 results at 6:55 a.m. (ET) on July 28, 2026. At 9:00 a.m. (ET), Xylem’s senior management team will host a conference call with investors. The call can be accessed by calling +1 (866) 777-2509 (US) or +1 (412) 317-5413 (INTL) or by visiting Investors Events | Xylem US. A replay of the briefin...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Six Flags Entertainment Corporation (NYSE: FUN) (“Six Flags” or the “Company”), North America’s largest regional amusement park operator, today announced the appointment of Mark Pauls as Chief Operating Officer, effective July 15, 2026. Pauls succeeds Tim Fisher, who will serve as a Special Advisor to the Company through December 15, 2026, to ensure a smooth transition.Mark Pauls is a disciplined operator with nearly five decades of experience in the entertainme...

法國里昂--(BUSINESS WIRE)--(美國商業資訊)-- Brenus Pharma今日宣布其董事會的重要人事任命。該公司歡迎Eric DESSERTENNE擔任總裁兼董事會主席，接替將繼續留任為活躍董事會成員的共同創辦人Jacques GARDETTE。Eric在醫療保健創新與價值創造方面擁有豐富經驗，曾主導BIOCORP的發展歷程及其後續由Novo Nordisk收購之事宜。Brenus亦任命Camilla SYLVEST為第二位獨立董事，並且此前已延攬資深且深耕美國生技領域的高階主管及企業家Diala EZZEDDINE。 Camilla SYLVEST是一位經驗豐富的製藥高階主管與全球商業領袖，曾在Novo Nordisk A/S服務近三十年，其最後職務為全球商業策略、企業溝通與永續發展執行副總裁。她目前擔任Argenx SE、Getinge AB及Zealand Pharma A/S之董事會成員，亦曾為Danish Crown A/S董事會成員，並擔任過世界糖尿病基金會副主席。 Brenus Pharma執行長Paul BRAVETTI表示：「Eric出色的實績，加...

LYON, Francia--(BUSINESS WIRE)--Brenus Pharma acaba de anunciar varios nombramientos clave para su consejo de administración. La empresa da la bienvenida a Eric DESSERTENNE como presidente. Asimismo, ocupará la presidencia del consejo de administración en sustitución del cofundador Jacques GARDETTE, quien seguirá siendo miembro activo del consejo. Eric aporta una amplia experiencia en innovación sanitaria y creación de valor después de haber dirigido con éxito BIOCORP a lo largo de su desarroll...

LIONE, Francia--(BUSINESS WIRE)--Brenus Pharma oggi ha annunciato importanti novità nel proprio consiglio di amministrazione. L'azienda dà il benvenuto a Eric DESSERTENNE, che assume il doppio incarico di presidente dell'azienda e del consiglio di amministrazione al posto del co-fondatore Jacques GARDETTE, che mantiene una partecipazione attiva nel CdA. Eric apporta una vasta esperienza nell'innovazione e nella creazione di valore nel comparto sanitario, maturata in particolare in BIOCORP nel c...